IMCD N.V. (“IMCD”), a leading distributor of speciality chemicals and ingredients, has entered into a share purchase agreement on 26 November 2020 to acquire the personal care business of Ejder Kimya İlaç Danışmanlık Sanayi ve Ticaret A.Ş (“Ejder Kimya”). The transaction is expected to close in January 2021, subject to customary closing conditions and regulatory approval.
Paksoy is pleased to announce that a team led by Elvan Aziz (partner) together with Gözde Zorlu (associate) and Simge Şengün (associate) acted as Turkish counsel to IMCD on this transaction.
Share
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
25 November 2025
Paksoy Celebrates 7 GBM Awards at 2025
Paksoy celebrates 7 GBM Awards at 2025, showcasing our strength in complex debt finance, sukuk, project finance & private credit.
19 November 2025
Paksoy advises Founders on their sale of Apsiyon
Paksoy advises Founders on their sale of Apsiyon
7 November 2025
We maintain our Tier 1 rankings across all IFLR1000 2025 practice areas
We maintain our Tier 1 rankings across all IFLR1000 2025 practice areas. Being ranked Tier 1 across all IFLR1000 practice areas for Türkiye…
31 October 2025
Paksoy has advised Türk Telekom on its inaugural USD 600 million 5-year sukuk issuance
Paksoy has advised Türk Telekom on its inaugural USD 600 million 5-year sukuk issuance.
31 October 2025
Paksoy advised Borusan Next on the acquisition of Carvak
Paksoy advised Borusan Next on the acquisition of Carvak.
27 October 2025
Paksoy has advised the international syndicate consisting of IFC, AIIB, FMO and Green for Growth Fund, on the USD 340 million financing transaction with Enerjisa
Paksoy has advised the international syndicate consisting of IFC, AIIB, FMO and Green for Growth Fund, on the USD 340 million financing…
